BANGKOK (The Nation/ANN): Japan is preparing to send Avigan, a drug used for treating influenza, to 38 countries this week, with four Asean countries -- the Philippines, Malaysia, Indonesia and Myanmar -- joining the trial for Covid-19 patients.
Japan's Minister for Foreign Affairs Toshimitsu Motegi said that Avigan, also known as Favipiravir, would be dispatched this week free of charge to be used in experiments to treat patients with Covid-19.
"The drug is effective in treating patients with Covid-19, especially in people with mild symptoms," added Motegi. Motegi said Japan would work with countries receiving the drug to expand clinical research on the efficacy of treating patients with Covid-19 .Japan will also give US$1 million to the United Nations to buy and deliver the medicine to the countries in need.- The Nation/Asia News Network
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Most Asean markets end higher as some global lockdown curbs easeSINGAPORE: Most Southeast Asian stock markets recouped losses from early trade to close higher on Tuesday, as optimism from the easing of lockdown measures in some coronavirus hotspots across the world outweighed gloom stemming from a fresh decline in oil prices
Read more »
Closely watched arthritis drug disappoints in Covid-19 trialWASHINGTON (AFP): An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said on Monday (April 27).
Read more »
After Remdesivir, second drug disappoints in Covid-19 trial | New Straits TimesNSTworld: An arthritis drug that was being closely watched for its potential use against Covid19 has delivered disappointing results in clinical trials, its makers said. coronavirus Kevzara
Read more »
Closely watched arthritis drug disappoints in Covid-19 trial | Malay MailWASHINGTON, April 28 — An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said yesterday. Kevzara, which is made by Regeneron and Sanofi, does not attack the novel coronavirus but instead...
Read more »
Hopes for Covid-19 drug dashed in virus trial | The Malaysian InsightArthritis drug does not attack Covid-19 but inhibits cytokine storm.
Read more »
Police: Drug distribution syndicate busted with arrests of four individuals, RM1m narcotics, cash, vehicle seized | Malay MailKUALA LUMPUR, April 27 — Police busted a drug distribution syndicate following the arrests of five individuals in several locations throughout the city centre last week, including seizing narcotics worth almost RM885,000. City police chief Commissioner Datuk Seri Mazlan Lazim said the first...
Read more »